The resources on this page are all created by the CTC-SRH to assist clinical services providers in managing common sexual and reproductive health concerns and related preventive health care issues. Some resources are helpful before, during, and after clinical encounters as quick reference guides, while others are focused at implementing or improving new services or protocols.
To find trainings with CE, browse our Training Tool Library
This job aid offers providers a quick reference guide to screening and staging syphilis.
This algorithm will support providers in staging and treatment for early primary, secondary, and early latent syphilis.
This job aid offers providers a quick reference guide to syphilis treatment.
This algorithm assists providers in treating clients considered to have late latent syphilis (>1 year duration) or syphilis of unknown duration.
This patient information resource can be offered to clients who are interested in or who have been prescribed Doxy PEP as a post-exposure prophylaxis to prevent the acquisition of gonorrhea, chlamydia, and syphilis.
Title X agencies should have all patient-facing materials, such as the handout above, reviewed and adapted by their Informational & Educational (I&E) Advisory Committee. Learn more about I&E Materials Review.
This job aid supports providers in counseling, prescribing, and monitoring Doxy PEP as a post-exposure prophylaxis to prevent the acquisition of gonorrhea, chlamydia, and syphilis.
This algorithm assists providers in screening for syphilis starting with an initial nontreponemal test (e.g., Venereal Disease Research Laboratory [VDRL] or rapid plasma reagin [RPR] test) then confirming positive results with a reflex treponemal antibody detection test (e.g., fluorescent treponemal antibody absorbed [FTA-ABS] test, chemoluminescence immunoassays [CIA], enzyme immunoassays [EIA], or T pallidum particle agglutination [TP-PA] test).
This algorithm assists providers in screening for syphilis, starting with an initial automated treponemal test (e.g., fluorescent treponemal antibody absorbed [FTA-ABS] test, chemoluminescence immunoassays [CIA], enzyme immunoassays [EIA], or T pallidum particle agglutination [TP-PA] test) and then confirming positive results with a reflex nontreponemal test (e.g., Venereal Disease Research Laboratory [VDRL] or rapid plasma reagin [RPR] test).
As part of the Combatting Congenital Syphilis trilogy, the CTC-SRH speaks with Louisiana Department of Health's Michael Carter, a regional STD Control manager, and Ariel Johnson, a disease intervention specialist (DIS)/contact tracer, about their role in addressing syphilis and HIV and how clinicians and DIS can leverage relationships to help their communities.
The Centers for Disease Control and Prevention (CDC) recently released Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention on June 6, 2024. This report is the first to outline the CDC's recommendation for the use of doxycycline postexposure prophylaxis (doxy PEP).
Learn more by watching our recorded DIALS from November 2023. Dr. Hilary Reno's slides outline the evidence base for doxy PEP.
This job aid demonstrates a tray set up for the provision of vasectomy services.
In this DIALS, recorded on May 17th, 2024, Dr. Amanda Morgan and Dr. Cheryl Radeloff discuss the current state of sex work in the US, cover priority health needs and strategies for meeting unmet needs of sex workers, and discuss client-led counseling and education approaches for people involved in sex work.
